Industry Insights: Genomic Testing for Early-Stage Breast Cancer - Poll - MDSpire

Industry Insights: Genomic Testing for Early-Stage Breast Cancer

William Audeh, Chief Medical Officer at Agendia, discusses recent data supporting genomic testing results in guiding clinical decision-making

  • March 27, 2026

  • 8 min

Share

Original Source(s)

Industry Insights: Genomic Testing for Early-Stage Breast Cancer

  • March 27, 2026

Related Content

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship